33 results on '"Fuller, Gregory"'
Search Results
2. RARE-23. DIFFUSE LEPTOMENINGEAL GLIONEURONAL TUMOR: A CASE SERIES
3. RARE-19. PEDIATRIC HIGH GRADE GLIOMA WITH DNA REPAIR PATHWAY ABERRATIONS, CLINICAL CHARACTERISTICS AND OUTCOME
4. NIMG-62. AMPHETAMINE-ASSOCIATED CNS VASCULITIS MASQUERADING AS TUMOUR
5. PATH-05. A RETROSPECTIVE STUDY OF TREATMENT STRATEGIES AND OUTCOMES IN WHO GRADE II AND III ISOCITRATE DEHYDROGENASE (IDH) WILD-TYPE ASTROCYTOMA
6. Window-of-opportunity clinical trial of pembrolizumab in patients with recurrent glioblastoma reveals predominance of immune-suppressive macrophages
7. REST-DRD2 mechanism impacts glioblastoma stem cell–mediated tumorigenesis
8. Guiding the first biopsy in glioma patients using estimated Ki-67 maps derived from MRI: conventional versus advanced imaging
9. RARE-13. CHARACTERIZATION OF ADULT MEDULLOBLASTOMA PATIENTS AT RECURRENCE: RETROSPECTIVE REVIEW OF THE MD ANDERSON CANCER CENTER EXPERIENCE
10. ATIM-07. WINDOW-OF-OPPORTUNITY CLINICAL TRIAL OF PEMBROLIZUMAB IN RECURRENT GLIOBLASTOMA PATIENTS
11. Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival
12. CSIG-04. IMMUNE CHECKPOINT BLOCKADE AS A POTENTIAL THERAPEUTIC TARGET: SURVEYING CNS MALIGNANCIES
13. RARE-63. MULTICENTRIC GLIOMA IN OLLIER DISEASE: A CASE REPORT AND REVIEW OF THE LITERATURE
14. IMST-49. MECHANISM AND THERAPEUTIC TARGETING OF OSTEOPONTIN-MEDIATED IMMUNE SUPPRESSION IN GBM
15. TMIC-04. GLIOBLASTOMA-ASSOCIATED MYELOID CELLS DISPLAY NONPOLARIZED M0 MACROPHAGE PHENOTYPE
16. RARE-61. CLINICAL, RADIOLOGIC, AND PATHOLOGIC REVIEW OF ASTROBLASTOMA: THE MD ANDERSON EXPERIENCE
17. RARE-26. GLIOMATOSIS, TO BE OR NOT TO CEREBRI: AN EVALUATION OF HOST SYSTEMIC IMMUNE FACTORS THAT POTENTIALLY PREDISPOSE TO DIFFUSE INFILTRATIVE GLIOMA PATTERNS
18. IMST-41. PARALLEL PROFILING OF MUTATIONAL LANDSCAPE, GENE EXPRESSION, AND T-CELL RECEPTOR REPERTOIRES IN SUBEPENDYMOMA REVEALS IMMUNOPHENOTYPIC HETEROGENEITY
19. Immune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies
20. IMPS-34INNATE IMMUNOLOGICAL COMPENSATORY CONTROL OF GLIOMAGENESIS AND MALIGNANT TRANSFORMATION IN MURINE CD8α KNOCKOUT MODELS
21. Percentage of mesenchymal stem cells in high-grade glioma tumor samples correlates with patient survival.
22. Signal transducer and activator of transcription 3 promotes angiogenesis and drives malignant progression in glioma
23. Expression of the splicing regulator polypyrimidine tract-binding protein in normal and neoplastic brain
24. The prognostic value of neurologic function in astrocytic spinal cord glioma
25. Toward better early-phase brain tumor clinical trials: A reappraisal of current methods and proposals for future strategies
26. Paraneoplastic chorea: Case autopsy confirmation study with
27. Paraneoplastic chorea: Case study with autopsy confirmation
28. Limitations of stereotactic biopsy in the initial management of gliomas
29. Survivin transcript variant 2 drives angiogenesis and malignant progression in proneural gliomas.
30. Tumor invasion after treatment of glioblastoma with bevacizumab: radiographic and pathologic correlation in humans and mice.
31. Toward better early-phase brain tumor clinical trials: A reappraisal ofcurrent methods and proposals for future strategies.
32. FIRST-IN-HUMAN PHASE I CLINICAL TRIAL OF ONCOLYTIC DELTA-24-RGD (DNX-2401) WITH BIOLOGICAL ENDPOINTS: IMPLICATIONS FOR VIRO- IMMUNOTHERAPY.
33. PRESENCE OF A DISTINCTIVE MYELOID POPULATION IS ASSOCIATED WITH THE INVASIVE TUMOR PHENOTYPE OBSERVED AFTER ANTI-ANGIOGENESIS THERAPIES.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.